D. Mero
Growth at reasonable price, healthcare, newsletter provider

Uplisting To Expand Organovo's Valuation

Organovo's (NYSEMKT:ONVO) investors were rewarded with a pleasant surprise on July 9th as the company announced that it had been approved to uplist on the NYSE MKT. Though its shares began trading on the New York Stock Exchange two days later, on July 11th, the reaction to the news was immediate. Since the release, shares of the 3D bioprinting company are up more than 50% on volume eight times the three month average. Overcoming the OTC stigma through the uplisting catalyst had been expected as it was mentioned on several occasions by CEO Keith Murphy who highlighted the milestone by ringing the opening NYSE bell on July 15th. This switch is a crucial event in Organovo's strives towards...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details